Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.3 USD | -0.24% | +0.19% | -2.54% |
Apr. 29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.54% | 186B | |
-1.85% | 107B | |
-4.26% | 67.44B | |
+1.39% | 50.03B | |
+16.82% | 47.81B | |
+5.56% | 41.03B | |
+3.49% | 26.85B | |
+0.65% | 25.82B | |
+17.18% | 24.74B | |
+0.01% | 25.01B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Earnings Flash (ABT) ABBOTT Posts Q1 Revenue $9.96B, vs. Street Est of $9.87B